Prescription pattern of anti-malarial drugs in a tertiary care hospital

Asian Pacific Journal of Tropical Medicine

Volumn 3, Issue 5, 2010, Pages 379-381

  Santoshkumar, R Jeevangi ^a   Manjunath, S ^a   Sharanabasappa, M Awanti ^a  

^a M R MEDICAL COLLEGE   (India)

Author keywords

Artesunate; Chloroquine; Drug use indicators; Drug utilization; Malaria

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ARTEETHER; ARTESUNATE; CHLOROQUINE; GENERIC DRUG; MEFLOQUINE; PRIMAQUINE; QUININE;

ADULT; AGED; ANOREXIA; ARTICLE; COMBINATION CHEMOTHERAPY; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; FEMALE; GENERAL HOSPITAL; HUMAN; HYPOGLYCEMIA; INDIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MONOTHERAPY; NAUSEA; PLASMODIUM VIVAX MALARIA; PRESCRIPTION; PROSPECTIVE STUDY; TERTIARY HEALTH CARE; TINNITUS; VOMITING;

EID: 77953261328     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(10)60092-2     Document Type: Article

References (19)

1. Berman JD, Nielsen R, Chulay JD, Dowler M, Kain KC, Kester KE, et al. Casual prophylactic efficacy of atovaquone-proguanil (Malarone) in a human challenge model. Trans R Soc Trop Med Hyg 2001, 95:429-432.
2. Park K Parks textbook of preventive and social medicine 2009, 222-223. M/S Branarsidas Bhanot Publishers, Jabalpur India. 20th edition.
3. World Health Organization. World malaria report; 2008.
4. Government of India Annual report 2003-2004 2004, Ministry of Health and Family Welfare, New Delhi.
5. Newton PN, Dondrop A, Green M Counterefeit artesunate antimalarials in southeast Asia. Lancet 2003, 362:169.
6. Meshnick SR Artemisinin and its derivates. Antimalarial chemotherapy: mechanism of action, resistance and new directions in drug discovery 2001, 191-201. Humana Press, Totowa, NJ. P.J. Rosenthal (Ed.).
7. Klayman DL Qinghaosu (artemisinin): An antimalarial drug from China. Science 1985, 228:1049-1055.
8. Newton PN, Angus BJ, Chierakul W, Dondorp A, Ruangveerayuth R, Silamut K, et al. Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria. Clin Infect Dis 2003, 37:7-16.
9. Bakssas I, Lunde PKM National drug policies; the need for drug utilization studies. Trends Pharmacol Sci 1986, 7:331.
10. World Health Organization How to investigate drug use in health facilities; selected drug use indicators 1993, 1. World Health Organization. WHO/DAP, Geneva, 1-87.
11. Shapiro TA, Goldberg DE Chemotherapy of protozoal infections malaria. Goodman and Gilmans, the pharmacological basis of therapeutics 2006, 1045. Mc Graw-Hill, New Delhi. 11th edition. L.L. Brunton, J.S. Lazo, K.L. Parker (Eds.).
12. White N Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci 1999, 354:739-749.
13. Limburg PJ, Katz H, Grant CS, Service FJ Quinine induced hypoglycemia. Ann Intern Med 1993, 119:218-219.
14. Biswas NR, Jindal S, Siddiquei MM, Maini R Pattern of prescription and drug use in ophthalmology in a tertiary hospital in Delhi. Br J Clin Pharmacol 2001, 51:267-269.
15. Biswas NR, Biswas RS, Pal PS, Jain SK, Malhotra SP, Gupta A, et al. Patterns of prescriptions and drug use in two tertiary hospital in Delhi. Indian J Physiol Pharmacol 2000, 44:109-112.
16. Lau GSN, Chan JCN, Chu PLM, Tse DCK, Critchley JAJH Use of antidiabetic and antihypertensive drugs in hospital and outpatient setting in HongKong. Ann Pharmacother 1996, 30:232-237.
17. Taylor WR, White NJ Antimalarial drug toxicity: A review. Drug Saf 2004, 27:25-61.
18. Dondorp A, Nosten F, Stepniewska K, Day N, White N Artesunate versus quinine for treatment of severe falciparum malaria: A randomized trial. Lancet 2005, 366:717-725.
19. Ridley RG Medical need, scientific opportunity and the drive for antimalarial drugs. Nature 2002, 415:686-693.